Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Mounting Evidence That Agent Orange Exposure Ups Prostate Cancer Risk
Link ID 33829
Title Mounting Evidence That Agent Orange Exposure Ups Prostate Cancer Risk
Url http://www.medscape.com/viewarticle/737921?src=rss
Description A study of nearly 3000 veterans showed that men exposed to Agent Orange in Vietnam were 49% more likely to be diagnosed with prostate cancer than men who were not exposed to the defoliate. Medscape Medical News
Category Articles > Hematology-Oncology
Keywords
Date Feb 25, 2011
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. Tragedy Not to Use EGFR Inhibitors in EGRF+ NSCLC Tragedy Not to Use EGFR Inhibitors in EGRF+ NSCLC
  Data are accumulating to support the treatment of patients with nonsmall-cell lung cancer who test EGFR-positive with one of the EGFR tyrosine kinase inhibitor drugs. br / iMedscape Medical News/i
Category:   Articles > Hematology-Oncology


2. AACR-NCI-EORTC 2009 International Conference on Molecular Targets and Cancer Therapeutics
  Read clinically focused news coverage of key developments from the meeting. Medscape Hematology-Oncology
Category:   Articles > Hematology-Oncology


3. How Low Would You Go?
  In this video blog, Dr. Kathy Miller discusses factors affecting the use of systemic adjuvant therapy for HER2 breast cancer patients who have small tumors. Medscape Hematology-Oncology
Category:   Articles > Hematology-Oncology


4. Supplementation With Vitamins C and E or Beta-Carotene May Not Prevent Cancer
  In a double-blind, placebo-controlled trial, supplementation with vitamin C, vitamin E, or beta-carotene did not help in the primary prevention of total cancer incidence or cancer mortality. Medscape Medical News
Category:   Articles > Hematology-Oncology


5. Benefits and Risks of Trastuzumab in Breast CancerBenefits and Risks of Trastuzumab in Breast Cancer
  A systematic review shows that trastuzumab significantly increases survival in women with HER2-positive breast cancer, but also puts them at risk for heart problems. Medscape Medical News
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS